What is Lamictal Used For? Uses, Dosing, and Side Effects Explained
Author:
Blossom Editorial
May 1, 2026
Lamictal (lamotrigine) is a medication with two primary uses: treating epilepsy and helping manage bipolar disorder. While it was first approved in the 1990s, its role in psychiatry has grown over time — especially for people who experience frequent depressive episodes in bipolar disorder.
Unlike some mood stabilizers (such as lithium and valproate) that are more effective for mania, lamotrigine is often used to help prevent depressive episodes of bipolar disorder. These episodes can last longer and are typically more difficult to treat, which makes prevention an important part of long-term care.
If you or someone you know has been prescribed Lamictal, or is considering it, this guide covers what it is, what conditions it treats, how dosing works, what side effects to expect, and key safety considerations.
Key Takeaways
Lamictal (lamotrigine) is FDA-approved for epilepsy and for maintenance treatment of bipolar I disorder. It is a preventive medication and helps reduce the frequency and severity of future mood episodes in bipolar I, especially depression.
It must be started at a low dose and increased slowly over several weeks. This helps reduce the risk of a rare but potentially life-threatening skin reaction called Stevens-Johnson syndrome (SJS).
It is sometimes used off-label for conditions like bipolar II disorder, treatment-resistant depression, and borderline personality disorder, though evidence varies by condition.
What is Lamictal?
Lamictal belongs to a class of drugs called anticonvulsants, originally developed to treat epilepsy by stabilizing electrical activity in the brain. The FDA first approved lamotrigine in 1994 for epilepsy and later approved it in 2003 for maintenance treatment of bipolar I disorder.
While most psychiatric medications primarily work through the dopamine or serotonin systems, lamotrigine helps stabilize electrical activity in the brain. It works by:
Blocking voltage-sensitive sodium channels
Reducing the release of glutamate, an excitatory neurotransmitter
These effects can help calm overactive brain signaling. In bipolar disorder, this appears to make Lamictal more effective at preventing depressive episodes than manic episodes.
FDA-Approved Uses
Bipolar I Disorder Maintenance
Lamictal is approved for maintenance treatment of bipolar I disorder. This means that it helps delay or prevent the recurrence of mood episodes in people who are already stable.
It is not approved to treat acute manic or depressive episodes, and it is generally not used as a stand-alone treatment during active episodes.
A pivotal clinical trial published in the Journal of Clinical Psychiatry suggests that lamotrigine (Lamictal) significantly reduced the frequency of recurrence of any mood episode compared to placebo in bipolar I patients. The results were particularly strong for preventing depressive episodes.
This antidepressant effect of Lamictal is different from lithium, which is generally considered a better option to prevent mania.
Epilepsy
Lamictal is also FDA-approved as adjunct therapy for several types of seizures, including:
Partial-onset seizures
Generalized tonic-clonic seizures
Seizures associated with Lennox-Gastaut syndrome in both adults and children
It may be used as a standalone first-line treatment in some epilepsy cases or alongside other anti-seizure medications, depending on the situation.
Off-Label Uses in Psychiatry
In clinical practice, Lamictal is sometimes prescribed off-label, meaning for uses not specifically approved by the FDA. Evidence is supportive but varies depending on the situation in:
Bipolar II disorder: Lamictal is often used for bipolar II when depressive episodes are more prominent. While not FDA-approved for Bipolar II, limited evidence suggests that it may help reduce depressive recurrences, and it is often recommended in treatment guidelines from major psychiatric organizations.
Treatment-resistant depression: Sometimes added to antidepressants when major depression does not respond well to standard treatments. It is typically used in people with suspected bipolar symptoms or who have not responded well to multiple antidepressants.
Borderline personality disorder (BPD): Several randomized controlled trials suggest it may help with mood instability and emotional reactivity, though findings are mixed.
Post-traumatic stress disorder (PTSD): Limited evidence suggests potential benefit for mood instability and emotional reactivity in PTSD as well.
How is Lamictal Dosed?
Lamictal must be started slowly and increased over time. This is because rapid dose increases are a primary risk factor for Stevens-Johnson syndrome (discussed below). Here’s how Lamictal dosing works:
Standard Bipolar Maintenance Schedule (No Interacting Drugs)
Weeks 1 to 2: 25 mg once daily
Weeks 3 to 4: 50 mg once daily
Week 5: 100 mg once daily
Week 6 and beyond: Typical target dose of 200 mg/day
Some people may require adjustments within a range of 100 to 400 mg/day, depending on response and tolerability.
Dose Adjustments for Drug Interactions
Certain medications can significantly affect Lamictal levels:
With valproate (Depakote):
Valproate can inhibit the breakdown of Lamictal in the body, which can lead to increased blood levels. To manage this, usually the starting dose is halved (25 mg every other day), and the target dose is typically lower (100 mg/day).
With carbamazepine or phenytoin:
These drugs can speed up Lamictal’s breakdown in the body, leading to reduced levels.This, in turn, may require roughly double the standard dose to achieve therapeutic levels.
With hormonal contraceptives:
Oral contraceptives can reduce Lamictal blood levels significantly. Women starting or stopping the pill while on Lamictal may need dose adjustments and should discuss this with their healthcare provider.
Because these interactions can affect safety, it’s important to review all medications with your healthcare provider before starting treatment.
Side Effects
Lamictal is generally considered well-tolerated, especially compared to some other mood stabilizers. It is less commonly associated with:
Weight gain
Sedation
Cognitive decline
Thyroid disruption
Unlike lithium, it typically doesn’t require regular monitoring of blood levels. And unlike valproate, it typically does not increase the risk of liver toxicity. These advantages can make it a preferred long-term option for many patients.
Common side effects include:
Headache — one of the most frequently reported side effects, often transient
Dizziness or unsteadiness — more common during the dose adjustment phase
Nausea or vomiting — typically mild and often improves with food or dose timing adjustments
Blurred or double vision — particularly at higher doses or during rapid dose increments
Insomnia or somnolence — can go either way, depending on the individual
Rash — may require immediate evaluation; see the section below
Many side effects are more noticeable during the gradual dose increment phase and may improve as the dose stabilizes.
The Critical Rash Warning: Stevens-Johnson Syndrome
A rare but serious risk of Lamictal (lamotrigine) is Stevens-Johnson syndrome (SJS) — a severe skin reaction that can become potentially life-threatening.
SJS is characterized by symptoms such as blistering and peeling of the skin. In its most severe form, called toxic epidermal necrolysis (TEN), it can be fatal.
According to the FDA prescribing information, most serious rashes occur within the first 2 to 8 weeks of treatment. The primary risk factors can include:
Starting at too high a dose
Increasing the dose too quickly
Having drug interactions that raise Lamictal blood levels unexpectedly, particularly with valproate
It is important to note that most rashes associated with Lamictal are mild and localized. Such rashes can occur and do not necessarily require stopping the medication. However, any rash must be reported to your healthcare provider immediately for evaluation. Seek urgent medical care for any rash, especially if it is accompanied by:
Blistering, peeling, or raw skin
Sores in the mouth, eyes, or genitals
Fever alongside a rash
Rapidly spreading redness or swelling
What to Expect When Starting Lamictal
Because of the gradual dose increment, it may take 6 to 8 weeks to reach a therapeutic dose.
Lamictal is a maintenance medication, so its benefits are often seen over time, such as less frequent, milder, or shorter mood episodes. This is what sets Lamictal apart from other medications like SSRIs, which can begin producing partial effects within one to two weeks. Tracking mood during the gradual increment phase can be helpful. Some people notice gradual improvement early on; while others may not feel clear benefits until they have been on a stable dose for several months.
Lamictal is typically taken once or twice daily and can be taken with or without food. Taking it consistently at the same time each day can help maintain steady levels in the body. Keeping a simple daily mood log to share with your healthcare provider can also help both of you assess whether the medication is working as expected.
When to Seek Professional Help
If you’re considering Lamictal (lamotrigine) or have questions about your treatment plan, speaking with a qualified provider can help you weigh your risks and benefits. Board-certified psychiatrists at Blossom Health offer virtual evaluations and ongoing care covered by in-network insurance. You can learn more or get started here.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. The information provided should not replace consultation with a qualified healthcare provider. Individual responses to medications can vary significantly, and what applies to one person may not be the same for another.
Always consult with your doctor or pharmacist before making any decisions about medication changes, discontinuation, or interactions with other substances. If you’re experiencing concerning symptoms or side effects, please seek professional help from a healthcare provider.
In case of a medical emergency, contact your local emergency services immediately or call 911. For mental health emergencies, contact the National Suicide Prevention Lifeline at 988.
Sources
FDA Prescribing Information. (March, 2015). Lamictal (Lamotrigine). https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s045s051lbl.pdf
Geddes, J. R., Calabrese, J. R., & Goodwin, G. M. (2009). Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. The British journal of psychiatry : the journal of mental science, 194(1), 4–9. https://doi.org/10.1192/bjp.bp.107.048504
Calabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O. P., Montgomery, P., Ascher, J., Paska, W., Earl, N., DeVeaugh-Geiss, J., & Lamictal 605 Study Group (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. The Journal of clinical psychiatry, 64(9), 1013–1024. https://doi.org/10.4088/jcp.v64n0906
National Institute of Mental Health. (December 2024). Bipolar Disorder. https://www.nimh.nih.gov/health/topics/bipolar-disorder
Cleveland Clinic. Lamotrigine (Lamictal). https://my.clevelandclinic.org/health/drugs/20217-lamotrigine-tablets
Frye M. A. (2011). Clinical practice. Bipolar disorder--a focus on depression. The New England journal of medicine, 364(1), 51–59. https://doi.org/10.1056/NEJMcp1000402
American Psychiatric Association (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). The American journal of psychiatry, 159(4 Suppl), 1–50. https://pubmed.ncbi.nlm.nih.gov/11958165/
Gitlin, M., & Frye, M. A. (2012). Maintenance therapies in bipolar disorders. Bipolar disorders, 14 Suppl 2, 51–65. https://doi.org/10.1111/j.1399-5618.2012.00992.x
